FDA Orange Book
Generic for Ddavp (needs No Refrigeration)
Ddavp (needs No Refrigeration) contains desmopressin acetate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Ddavp (needs No Refrigeration) is desmopressin acetate. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Ddavp (needs No Refrigeration) and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Ddavp (needs No Refrigeration) products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| spray, metered, nasal | 0.01MG/SPRAY | Discontinued | None | 2 | AB |
NDA 017922, held by FERRING PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic desmopressin acetate
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| APOTEX INC | 076703 | AB (A-rated, therapeutically equivalent) | January 27, 2005 | 0.01MG/SPRAY |
| ZYDUS PHARMACEUTICALS USA INC | 091345 | AB (A-rated, therapeutically equivalent) | October 3, 2017 | 0.01MG/SPRAY |
Questions
Is there a generic for Ddavp (needs No Refrigeration)?
Yes. The generic name for Ddavp (needs No Refrigeration) is desmopressin acetate. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Ddavp (needs No Refrigeration)?
The active ingredient in Ddavp (needs No Refrigeration) is desmopressin acetate, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.